| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0786 |
| Trial ID | ChiCTR1900021153 |
| Disease | Plasma Cell Neoplasm |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | An open-label, single-center and randomized controlled trial for anti-BCMA CAR-T cells with chemotherapy agents conditioning for patients with R/R plasma cell malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||